Asset Details
Do you wish to reserve the book?
Atypical myopathy: an update
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Atypical myopathy: an update
Do you wish to request the book?
Atypical myopathy: an update
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Atypical myopathy: an update
2016
Overview
Atypical myopathy is an acute intoxication induced by the ingestion of hypoglycin A, a toxin contained in the seeds and seedlings of certain trees of the genus Acer (particularly Acer pseudoplatanus [sycamore] in Europe), which results in disruption of the energy metabolism. The clinical signs arise from energy depletion in the type I fibres of the postural and respiratory muscles, and lead to a specific biochemical profile that may be used to confirm a diagnosis. Since there is no cure for the condition, the emphasis is on prevention, which requires knowledge of the conditions necessary for the causative agent to exert its toxicity. This article gives an overview of atypical myopathy, discussing the mechanism involved, its aetiology and the clinical signs and management (therapeutic and prevention).
Publisher
BMJ Publishing Group Limited,Blackwell Publishing Ltd,T. G. Scott & Son Ltd
Subject
We currently cannot retrieve any items related to this title. Kindly check back at a later time.